fda compounding glp-1 warning letters october 2025 CDER Jump 50% in FY — What That Means for Industry FDA Sends 30 Warning Letters

They are indicated for type 2 diabetes management, weight reduction in obesity, and cardiovascular risk reduction, with ongoing investigation into metabolic dysfunction-associated steatohepatitis, chronic kidney disease, and heart failure with preserved ejection fraction

We are ready to fight tirelessly pursue your full and fair recovery

Some people can safely take GLP-1s to lose weight postpartum, but there are several important precautions

Every womans hair loss journey is different

Were just making sure Lupes recipes, her touch, and that sense of home live on in this next chapter. Frank & Lupes Gainey Ranch is expected to open in spring 2026